William Blair Begins Coverage of Anthropic at Outperform

Analyst: Arjun Bhatia 1 min read Reproduced verbatim
Rating
Outperform
New coverage
Target
N/A
No target in this note
Upside
N/A
No target to measure

The median of 4 current targets on Anthropic is $143.

William Blair and Anthropic logos

What the analyst said

William Blair analyst Arjun Bhatia initiates coverage on Anthropic (NASDAQ: ANT) with an Outperform rating.

“We are launching coverage of Anthropic with an Outperform rating following our deep dive on Anthropic from last week: Anthropic: Pushing the Frontier Pays for Itself. Note that pricing in this note is as of the IPO on November 18, 2026. In our view, AI is a revolutionary technology, and Anthropic is at the forefront of developing and commercializing AI through its frontier models.

As with any market in its nascency, there is a lot that is uncertain about the future, including the pace and direction in which it may unfold. Questions about the future are worth asking, even those that don’t have an answer at this point.

The risks around competition, model pricing, data centers, and regulation are real. However, we don’t want to miss the forest for the trees. We think AI is a generational shift in the tech landscape, and Anthropic is leading the charge in developing AI with a select handful of other companies.

Over the next decade, we think Anthropic is only going to become more important and consume a greater portion of enterprise spend. Our positive view and Outperform rating rests on three simple observations: 1) the AI TAM is large (in the multiple trillions of dollars) and still in its very early days; 2) Anthropic leads the commercialization of frontier AI in the enterprise, and 3) the economics and long-term profitability potential of the business model are attractive.

On valuation, we believe the multiple is very reasonable at 9x our 2027 revenue estimate and 6x our 2028 revenue. This is a discount to many other leading tech companies that have much slower growth rates. We believe 17x-20x revenue would not be an unreasonable multiple, implying a price of $130-$150.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share Reddit StockTwits
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.